
Tricida TCDA
Quartalsbericht 2022-Q3
hinzugefügt 14.11.2022
Tricida ROE 2011-2026 | TCDA
ROE Jährlich Tricida
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -80993.58 | -243.22 | -67.0 | -52.85 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -52.85 | -80993.58 | -20339.16 |
ROE Vierteljährlich Tricida
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.41 | -2008.55 | -4113.45 | -4235.16 | -2268.7 | -2319.08 | -304.45 | -261.82 | -243.22 | -214.89 | -160.27 | -120.72 | -67.0 | -59.27 | -57.51 | -56.67 | -52.85 | -15.2 | 12.04 | 33.85 | 44.39 | 21.05 | 8.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 77.41 | -4235.16 | -711.36 |
ROE anderer Aktien in der Arzneimittelhersteller
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alimera Sciences
ALIM
|
-43.6 | - | - | $ 142 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
3276.74 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
431.6 | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
-122.76 | $ 1.26 | -1.94 % | $ 136 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
-162.53 | - | 7.5 % | $ 6.35 M | ||
|
Cronos Group
CRON
|
-4.28 | $ 2.67 | 0.57 % | $ 1.42 B | ||
|
Agile Therapeutics
AGRX
|
88.64 | - | 10.11 % | $ 58.2 M | ||
|
Catalent
CTLT
|
-28.94 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
-186.86 | - | - | $ 50.1 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
-50.54 | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
-98.17 | - | 2.45 % | $ 38.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
15.26 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
37.13 | - | - | $ 28.9 M | ||
|
Emergent BioSolutions
EBS
|
-117.13 | $ 13.18 | -1.35 % | $ 675 M | ||
|
Evoke Pharma
EVOK
|
302.08 | - | - | $ 36.6 M | ||
|
Athenex
ATNX
|
1589.72 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
-66.13 | $ 21.49 | 0.05 % | $ 2.04 B | ||
|
Evolus
EOLS
|
-913.07 | $ 5.5 | -4.12 % | $ 341 M | ||
|
Harrow Health
HROW
|
-34.5 | $ 49.05 | -3.9 % | $ 1.6 B | ||
|
China Pharma Holdings
CPHI
|
-61.13 | $ 1.31 | -3.32 % | $ 22.9 M | ||
|
Jupiter Wellness
JUPW
|
2273.74 | - | - | $ 33.6 M | ||
|
OrganiGram Holdings
OGI
|
-45.46 | $ 1.72 | -0.41 % | $ 402 M | ||
|
Organogenesis Holdings
ORGO
|
0.33 | $ 4.18 | -0.83 % | $ 550 M | ||
|
Bausch Health Companies
BHC
|
57.93 | $ 7.79 | 0.13 % | $ 2.84 B | ||
|
Lannett Company
LCI
|
92.26 | - | 1.15 % | $ 7.11 M | ||
|
Sundial Growers
SNDL
|
-88.87 | $ 1.64 | 0.01 % | $ 3.37 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
-78.37 | $ 3.77 | -0.28 % | $ 4.68 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
-8.33 | $ 4.77 | -1.24 % | $ 67.1 M | ||
|
Neoleukin Therapeutics
NLTX
|
7.34 | - | - | $ 193 M | ||
|
Tilray
TLRY
|
-43.81 | $ 9.42 | 3.14 % | $ 5.82 B | ||
|
Aurora Cannabis
ACB
|
-154.42 | $ 4.3 | 0.59 % | $ 86.3 M | ||
|
Veru
VERU
|
-116.97 | $ 2.39 | 3.46 % | $ 322 M | ||
|
Pacira BioSciences
PCRX
|
-12.79 | $ 22.6 | -13.16 % | $ 1.05 B | ||
|
PetIQ
PETQ
|
0.96 | - | 1.64 % | $ 400 M | ||
|
cbdMD
YCBD
|
-7.78 | $ 1.04 | -3.7 % | $ 4.49 M | ||
|
Perrigo Company plc
PRGO
|
-3.98 | $ 14.85 | 0.99 % | $ 2.04 B | ||
|
ProPhase Labs
PRPH
|
29.02 | - | - | $ 5.07 M | ||
|
Recro Pharma
REPH
|
-22.63 | - | -4.76 % | $ 65.3 M | ||
|
Radius Health
RDUS
|
27.81 | - | - | $ 1.42 B | ||
|
Rockwell Medical
RMTI
|
-39.64 | $ 0.96 | -2.11 % | $ 22.4 M | ||
|
Relmada Therapeutics
RLMD
|
-115.74 | $ 4.41 | -0.45 % | $ 133 M | ||
|
OptiNose
OPTN
|
40.97 | - | - | $ 1.08 B | ||
|
Assertio Holdings
ASRT
|
-240.53 | $ 9.25 | -0.64 % | $ 657 M | ||
|
PLx Pharma
PLXP
|
-129.32 | - | -27.8 % | $ 2.56 M | ||
|
Solid Biosciences
SLDB
|
-90.86 | $ 5.37 | 1.13 % | $ 219 M | ||
|
SCYNEXIS
SCYX
|
91.88 | $ 0.66 | -0.66 % | $ 31.6 M | ||
|
TherapeuticsMD
TXMD
|
-35.09 | $ 2.03 | -1.46 % | $ 21.2 M | ||
|
Viatris
VTRS
|
9.86 | $ 12.66 | 0.46 % | $ 15.3 B | ||
|
Zomedica Corp.
ZOM
|
-14.39 | - | -0.21 % | $ 98 M |